Once-daily versus twice-daily antiretroviral dosing in HIV-infected pregnant women

被引：0
|
作者：
Huynh, Terri [1 ]
Pettker, Christian M. [2 ]
Thung, Stephen F. [2 ]
Magriples, Urania [2 ]
Duzyj, Christina M. [2 ]
Han, Christina S. [2 ]
Ali, Unzila A. [2 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Yale Univ, New Haven, CT USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2012年 / 206卷 / 01期
关键词：
D O I：
10.1016/j.ajog.2011.10.602
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
584
引用
收藏
页码：S265 / S265
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjects
    Thompson, M
    DeJesus, E
    Richmond, G
    Wheeler, D
    Flaherty, J
    Piliero, P
    True, A
    Chiu, YY
    Zhang, Y
    McFalls, E
    Miralles, GD
    Patel, IH
    [J]. AIDS, 2006, 20 (03) : 397 - 404
  • [2] Steady-State Pharmacokinetics of Lamivudine Once-Daily Versus Twice-Daily Dosing in Chinese HIV-Infected Patients
    Ye, Min
    Wang, Lu
    Fu, Qiang
    Zhu, Zhu
    Li, Peng
    Li, Taisheng
    [J]. HIV CLINICAL TRIALS, 2010, 11 (04): : 230 - 237
  • [3] Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?
    Nachega, Jean B.
    Rosenkranz, Bernd
    Pham, Paul A.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2011, 5 : 645 - 651
  • [4] Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
    Stek, Alice
    Best, Brookie M.
    Wang, Jiajia
    Capparelli, Edmund V.
    Burchett, Sandra K.
    Kreitchmann, Regis
    Rungruengthanakit, Kittipong
    Cressey, Tim R.
    Mofenson, Lynne M.
    Smith, Elizabeth
    Shapiro, David
    Mirochnick, Mark
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (01) : 33 - 41
  • [5] Efficacy and safety of 48 weeks of enfuvirtide 180 mg once-daily dosing versus 90 mg twice-daily dosing in HIV-infected patients
    Wright, David
    Rodriguez, Allen
    Godofsky, Eliot
    Walmsley, Sharon
    Labriola-Tompkins, Emily
    Donatacci, Lucille
    Shikhman, Anna
    Tucker, Ernestine
    Chiu, Yu-Yuan
    Chung, Jain
    Rowell, Lucy
    DeMasi, Ralph
    Graham, Neil
    Salgo, Miklos
    [J]. HIV CLINICAL TRIALS, 2008, 9 (02): : 73 - 82
  • [6] Pharmacokinetics and Pharmacodynamics of Once-Daily versus Twice-Daily Raltegravir in Treatment-Naive HIV-Infected Patients
    Rizk, Matthew L.
    Hang, Yaming
    Luo, Wen-Lin
    Su, Jing
    Zhao, Jing
    Campbell, Havilland
    Nguyen, Bach-Yen T.
    Sklar, Peter
    Eron, Joseph J., Jr.
    Wenning, Larissa
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 3101 - 3106
  • [7] A clinical and pharmacologic assessment of once-daily versus twice-daily dosing for rivaroxaban
    Reinhold Kreutz
    [J]. Journal of Thrombosis and Thrombolysis, 2014, 38 : 137 - 149
  • [8] SLOW-RELEASE THEOPHYLLINE - ONCE-DAILY VERSUS TWICE-DAILY DOSING
    SCHMIDLIN, O
    VOZEH, S
    DIETZ, G
    PERRUCHOUD, A
    FOLLATH, F
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, : 28 - 28
  • [9] ONCE-DAILY VERSUS TWICE-DAILY DOSING OF DIGOXIN IN THE PEDIATRIC AGE GROUP
    ZALZSTEIN, E
    KOREN, G
    LEVY, M
    BENTUR, Y
    MACLEOD, S
    FREEDOM, R
    [J]. JOURNAL OF PEDIATRICS, 1990, 116 (01): : 137 - 139
  • [10] A clinical and pharmacologic assessment of once-daily versus twice-daily dosing for rivaroxaban
    Kreutz, Reinhold
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 38 (02) : 137 - 149
12345